Competition between STAT5 and NF-κB for common binding sites increased expression of STAT5 genes including Cyclin D2 and D3 (CCND2, CCND3) and the oncogene MYC (MYC) [185], driving an aggressive form of B-ALL. Here, STAT5B is linked to precursor B-cell acute lymphoblastic leukemia.